NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses - Top-Institutions - MDSpire

NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses

  • By

  • Salima Shebbo

  • Doaa Elsayed Mahmoud

  • Nooralhuda Alateyah

  • Seyedeh H. Hosseini

  • Amal Al-Haidose

  • Salam A. Ramirez

  • Asad Zeidan

  • Atiyeh M. Abdallah

  • May 5, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    UCSF Health – UCSF Medical Center
    UCSF Health – UCSF Medical Center

    San Francisco, CA

    Key Differentiators

    • Pulmonology
    • Oncology

  • #2

    Duke University Hospital and Duke Cancer Institute
    Duke University Hospital and Duke Cancer Institute

    Durham, NC

    Key Differentiators

    • Pulmonology
    • Oncology

Original Source(s)

NLRP3 inflammasomes at the ARDS-cancer interface: mechanisms and translational hypotheses

  • by Salima Shebbo, Doaa Elsayed Mahmoud, Nooralhuda Alateyah, Seyedeh H. Hosseini, Amal Al-Haidose, Salam A. Ramirez, Asad Zeidan, Atiyeh M. Abdallah

  • May 5, 2026

Related Content

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen